Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1980-12-09
1985-08-13
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514562, A61K 31465
Patent
active
045350825
ABSTRACT:
The potential of dyphylline as a bronchodilator is severely limited by its short half-life. By administering an anionic blocker prior to or concurrently with dyphylline, this shortcoming is overcome, and effective plasma levels can be maintained for as long as eight hours.
REFERENCES:
patent: 4348397 (1982-09-01), May et al.
Goodman & Gilman-The Pharmacological Basis of Therapeutics (Textbook), 6th ed., 1980, pp. 929-932.
Cunningham, R. F., et al., "Clinical Pharmacokinetics of Probenecid", Clinical Pharmacokinetics, 6:135-151, (1981).
Simons, K. J., and Simons, F. E. R., J. Pharm. Sci., 68, 1327-1328, Oct. 1979.
Research Communications in Chemical Pathology and Pharmacology, vol. 23, No. 3, 523-531, Mar. 1979.
Giscion, L. G., Ayres, J. W. & Ewing, G. H., Am. J. Hosp. Pharm., vol. 36, 1179-1184, Sep. 1979.
ByK Gulden Lomberg Chemische Fabrik GmbH
Schenkman Leonard
LandOfFree
Combining an anionic blocking agent with dyphylline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combining an anionic blocking agent with dyphylline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combining an anionic blocking agent with dyphylline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2318567